Biotech firm Synthego raises $200mn in funding from Softbank, others

Biotechnology firm Synthego said on Thursday it had raised $200m in a late-stage funding round led by hedge fund Perceptive Advisors, with participation from SoftBank Vision Fund 2.

Other investors in the Series E round included venture capital firms Moore Strategic Ventures, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund and Chimera Investments.

In December, biotech firm Freenome raised $300m in a late-stage funding round led by Perceptive Advisors and hedge fund RA Capital Management.

Last year, Synthego had raised $100m in a Series D round which drew investments from venture capital firms Wellington Management, Intel Capital and Menlo Ventures.